VRCA (STOCKS)
Verrica Pharmaceuticals Inc. Common Stock
$5.810000
+0.080000 (+1.40%)
Prev close: $5.730000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jayson M. Rieger
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $101.18M
- Employees
- 71
- P/E (TTM)
- -5.62
- P/B (TTM)
- 6.13
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.41 | $-0.37 | -0.0397 | -10.72% |
|
Dec 2025 (Q4)
|
$-0.46 | $-0.81 | +0.3502 | +43.22% |
|
Sep 2025 (Q3)
|
$-0.03 | $-0.69 | +0.6585 | +95.64% |
|
Jun 2025 (Q2)
|
$0.02 | $-0.72 | +0.7391 | +102.78% |
Financial Statements
| Revenues | $37.16M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $50.93M |
| Nonoperating Income/Loss | -$4.06M |
| Operating Expenses | $50.93M |
| Selling, General, and Administrative Expenses | $36.36M |
| Research and Development | $10.43M |
| Other Operating Expenses | $4.14M |
| Operating Income/Loss | -$13.77M |
| Income/Loss From Continuing Operations After Tax | -$17.83M |
| Income/Loss From Continuing Operations Before Tax | $24.66M |
| Net Income/Loss | -$17.83M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$17.83M |
| Net Income/Loss Available To Common Stockholders, Basic | -$17.83M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.11 |
| Diluted Earnings Per Share | -$1.11 |
| Basic Average Shares | 41,446,357 |
| Diluted Average Shares | 41,448,902 |
| Assets | $38.79M |
| Current Assets | $34.13M |
| Inventory | $1.97M |
| Other Current Assets | $32.16M |
| Noncurrent Assets | $4.66M |
| Fixed Assets | $191.00K |
| Other Non-current Assets | $4.47M |
| Liabilities | $22.73M |
| Current Liabilities | $16.22M |
| Accounts Payable | $2.19M |
| Wages | $862.00K |
| Other Current Liabilities | $13.16M |
| Noncurrent Liabilities | $6.51M |
| Equity | $16.06M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $16.06M |
| Liabilities And Equity | $38.79M |
| Net Cash Flow From Operating Activities | -$14.11M |
| Net Cash Flow From Operating Activities, Continuing | -$14.11M |
| Net Cash Flow From Investing Activities | $8.73M |
| Net Cash Flow From Investing Activities, Continuing | $8.73M |
| Net Cash Flow From Financing Activities | $5.38M |
| Net Cash Flow From Financing Activities, Continuing | $5.38M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$17.83M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$17.83M |
| Other Comprehensive Income/Loss | $0.00 |